Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Dentistry

 

FREE BLOG What does the Vitaldent scandal tell us?

An international dentistry group with EBITDA of €35m, which was about to start an auction process to sell to private equity, probably for an enterprise value of over €200m, has been engulfed in a scandal so bad that its very existence is in question (see our sepearate news story).

Scandal engulfs Vitaldent

Vitaldent, the big Spanish and Italian dentistry chain, has been engulfed in a tax scandal. This came a few weeks before an auction was about to start to sell the business, which boasted EBITDA of €35m. In 2015, PAI came close to paying €200m for the group. Observers say the brand has been trashed so badly that the group, which gets over half its sales from franchisees, may not survive.

BaltCap jumps on Estonian dentist

Estonian private equity house BaltCap is buying a 56% stake in the country's largest dental chain, Dental Invest Estonia (DIE). Martin Kõdar from BaltCap says the plan is to expand from general dentistry and orthodontics to new services like ear, nose and throat surgery.

Apollo to enter subscription market & Malaysia

India’s largest healthcare provider, Apollo Hospitals, plans to release a subscription healthcare product in 2016. This would be the first insurance product to cover outpatient services in the country, Neeraj Garg, CEO of Apollo Health and Lifestyle, told Healthcare Nova.

Report: Private healthcare in India

India’s healthcare sector has come a long way in a short time. Total healthcare expenditure (public and private) is $70bn and growing at astonishing rates - perhaps as high as 17% CAGR. In this 4,000 word report, we look in-depth at the booming inpatient and outpatient sectors and the prospects for broadening access to private healthcare.

Pihlajalinna plans war chest

Having IPOed as recently as June 2015, Finnish healthcare group Pihlajalinna is to ask shareholders for a mandate to issue an extra €40m in shares. The shares have soared 70% above the IPO price to over €17. A €40m issue would leave the company with €70m of net cash. What might the company buy and what does the move tell us about the Finnish market?

Find Us